Mevalonate Kinase Deficiency

DBCOND0001671Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesImmune System Diseases

Mevalonate Kinase Deficiency is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0501212ICD-10M04.1SNOMED CT124327008MedDRA10072010UMLSC0342731

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Mevalonate Kinase Deficiency share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In